This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Pfizer Inc.

Drug Names(s): PD-0200390, atagabalin

Description: PD-200,390 binds to the alpha-2-delta binding site, an auxiliary subunit of voltage-gated calcium channels. This site is thought to be responsible for the action of drugs such as Lyrica and Neurontin, which are used to treat epilepsy and neuropathic pain.

PD-200,390 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug